Literature DB >> 31189118

Distinct Neural Sites of GLP-1R Expression Mediate Physiological versus Pharmacological Control of Incretin Action.

Elodie M Varin1, Erin E Mulvihill1, Laurie L Baggio2, Jacqueline A Koehler2, Xiemin Cao2, Randy J Seeley3, Daniel J Drucker4.   

Abstract

Glucagon-like peptide 1 (GLP-1) receptors are widely distributed throughout the nervous system, enabling physiological and pharmacological control of glucose and energy homeostasis. Here we elucidated the importance of Glp1r expression within cellular domains targeted by expression of Wnt1-Cre2 or Phox2b-Cre. Widespread loss of neural Glp1r in Glp1rΔWnt1-/- mice had no effect on basal food intake, gastric emptying, and glucose homeostasis. However, the glucoregulatory actions of GLP-1R agonists, but not gut-selective DPP-4 inhibition, were preserved in Glp1rΔWnt1-/- mice. Unexpectedly, selective reduction of Glp1r expression within neurons targeted by Phox2b-Cre impaired glucose homeostasis and gastric emptying and attenuated the extent of weight loss achieved with sustained GLP-1R agonism. Collectively, these studies identify discrete neural domains of Glp1r expression mediating GLP-1-regulated control of metabolism and the gut-brain axis and reveal the unexpected importance of neuronal Phox2b+ cells expressing GLP-1R for physiological regulation of gastric emptying, islet hormone responses, and glucose homeostasis.
Copyright © 2019 The Author(s). Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  brain; enteric nervous system; glucagon-like peptide 1; gut hormones; metabolism; obesity; type 2 diabetes

Mesh:

Substances:

Year:  2019        PMID: 31189118     DOI: 10.1016/j.celrep.2019.05.055

Source DB:  PubMed          Journal:  Cell Rep            Impact factor:   9.423


  27 in total

Review 1.  Glucagon-like peptide 1 (GLP-1).

Authors:  T D Müller; B Finan; S R Bloom; D D'Alessio; D J Drucker; P R Flatt; A Fritsche; F Gribble; H J Grill; J F Habener; J J Holst; W Langhans; J J Meier; M A Nauck; D Perez-Tilve; A Pocai; F Reimann; D A Sandoval; T W Schwartz; R J Seeley; K Stemmer; M Tang-Christensen; S C Woods; R D DiMarchi; M H Tschöp
Journal:  Mol Metab       Date:  2019-09-30       Impact factor: 7.422

Review 2.  Peptide-Liganded G Protein-Coupled Receptors as Neurotherapeutics.

Authors:  Lee E Eiden; Ki Ann Goosens; Kenneth A Jacobson; Lorenzo Leggio; Limei Zhang
Journal:  ACS Pharmacol Transl Sci       Date:  2020-03-18

Review 3.  Central Nervous System Control of Glucose Homeostasis: A Therapeutic Target for Type 2 Diabetes?

Authors:  Zaman Mirzadeh; Chelsea L Faber; Michael W Schwartz
Journal:  Annu Rev Pharmacol Toxicol       Date:  2022-01-06       Impact factor: 13.820

Review 4.  Intestinal lipid absorption and transport in type 2 diabetes.

Authors:  Bruno Vergès
Journal:  Diabetologia       Date:  2022-07-30       Impact factor: 10.460

5.  A second-generation glucagon-like peptide-1 receptor agonist mitigates vomiting and anorexia while retaining glucoregulatory potency in lean diabetic and emetic mammalian models.

Authors:  Tito Borner; Evan D Shaulson; Ian C Tinsley; Lauren M Stein; Charles C Horn; Matthew R Hayes; Robert P Doyle; Bart C De Jonghe
Journal:  Diabetes Obes Metab       Date:  2020-06-25       Impact factor: 6.577

Review 6.  Multi-organ Coordination of Lipoprotein Secretion by Hormones, Nutrients and Neural Networks.

Authors:  Priska Stahel; Changting Xiao; Avital Nahmias; Lili Tian; Gary Franklin Lewis
Journal:  Endocr Rev       Date:  2021-11-16       Impact factor: 19.871

7.  Peripheral and central regulation of insulin by the intestine and microbiome.

Authors:  Jonathan D Schertzer; Tony K T Lam
Journal:  Am J Physiol Endocrinol Metab       Date:  2020-12-14       Impact factor: 4.310

Review 8.  Revisiting the Complexity of GLP-1 Action from Sites of Synthesis to Receptor Activation.

Authors:  Brent A McLean; Chi Kin Wong; Jonathan E Campbell; David J Hodson; Stefan Trapp; Daniel J Drucker
Journal:  Endocr Rev       Date:  2021-03-15       Impact factor: 19.871

Review 9.  Actions of glucagon-like peptide-1 receptor ligands in the gut.

Authors:  Jens Juul Holst; Daniel Bjørklund Andersen; Kaare Villum Grunddal
Journal:  Br J Pharmacol       Date:  2021-08-04       Impact factor: 8.739

10.  GLP-1 Receptor Signaling Differentially Modifies the Outcomes of Sterile vs Viral Pulmonary Inflammation in Male Mice.

Authors:  Takehiro Sato; Tatsunori Shimizu; Hiroki Fujita; Yumiko Imai; Daniel J Drucker; Yutaka Seino; Yuichiro Yamada
Journal:  Endocrinology       Date:  2020-12-01       Impact factor: 4.736

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.